Survival and Toxicity Outcomes with Radiotherapy Technique and Timing in the Management of Wilms Tumor: a Systematic Review to Inform a National Clinical Practice Guideline Development
Warren Bacorro, Jane Efflyn Lardizabal-Bunyi, Michelle Rodriguez, Maria Cecilia Leongson-Cruz
Oct 2024 DOI 10.35460/2546-1621.2024-0161 Access
Abstract
Purpose: Wilms tumor (WT) management has evolved into a multimodality paradigm that includes radiotherapy (RT), usually as an adjuvant or consolidative modality. Protocols are refined to maximize cure and compliance while minimizing acute toxicity and long-term effects. RT technique and timing are two factors that could improve these outcomes. We reviewed the evidence on survival and toxicity outcomes among WT patients with conventional versus advanced RT techniques and early versus delayed RT to inform a Department of Health (DOH) commissioned guideline.
Materials and Methods: We systematically searched PubMed, EuropePMC, EBSCOHost, HERDIN, systematic review and clinical trial registries and official websites of scientific societies for relevant publications and grey literature. Eligibility screening, risk-of-bias assessment and data extraction were performed using a single-reviewer approach. Given the study and data heterogeneity, only a qualitative synthesis was performed. Certainty of evidence assessment was done using the GRADE approach.
Results: We screened 314 studies and included seven in the review, including a phase 1/2 trial and six retrospective studies, all from first-world countries (US, France, Netherlands), except one from a newly industrialized country (Brazil). The certainty of evidence on the survival and toxicity outcomes with advanced RT techniques was very low. Moderate-certainty evidence supports that giving RT >14 days after surgery leads to increased mortality.
Conclusion: Current evidence does not support the routine use of advanced RT techniques; proper contextualization is necessary. Tertiary centers managing WT should strive to administer RT within 14 days after surgery whenever possible.
Keywords: Wilms tumor, nephroblastoma, radiotherapy, intensity-modulated radiotherapy, survival, toxicity
Study Registration: PROSPERO CRD42023393387
-
van Dijk IWEM, Oldenburger F, Cardous-Ubbink MC, Geenen MM, Heinen RC, de Kraker J, et al. Evaluation of late adverse events in long-term Wilms’ tumor survivors. Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):370–8.
-
van Waas M, Neggers SJCMM, Raat H, van Rij CM, Pieters R, van den Heuvel-Eibrink MM. Abdominal radiotherapy: a major determinant of metabolic syndrome in nephroblastoma and neuroblastoma survivors. PloS One. 2012;7(12):e52237.
-
Green DM, Lange JM, Peabody EM, Grigorieva NN, Peterson SM, Kalapurakal JA, et al. Pregnancy outcome after treatment for Wilms tumor: a report from the national Wilms tumor long-term follow-up study. J Clin Oncol Off J Am Soc Clin Oncol [Internet]. 2010;28(17):2824–30. Available from: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&AN=20458053&site=ehost-live
-
Kalapurakal JA, Peterson S, Peabody EM, Thomas PRM, Green DM, D’angio GJ, et al. Pregnancy outcomes after abdominal irradiation that included or excluded the pelvis in childhood Wilms tumor survivors: a report from the National Wilms Tumor Study. Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1364–8.
-
van der Perk MEM, Cost NG, Bos AME, Brannigan R, Chowdhury T, Davidoff AM, et al. White paper: Oncofertility in pediatric patients with Wilms tumor. Int J Cancer [Internet]. 2022 Sep 15;151(6):843–58. Available from: https://search.ebscohost.com/login.aspx?direct=true&db=mdc&AN=35342935&site=ehost-live
-
Warwick AB, Kalapurakal JA, Ou SS, Green DM, Norkool PA, Peterson SM, et al. Portal hypertension in children with Wilms’ tumor: a report from the National Wilms’ Tumor Study Group. Int J Radiat Oncol Biol Phys. 2010 May 1;77(1):210–6.
-
Breslow NE, Collins AJ, Ritchey ML, Grigoriev YA, Peterson SM, Green DM. End stage renal disease in patients with Wilms tumor: results from the National Wilms Tumor Study Group and the United States Renal Data System. J Urol. 2005 Nov;174(5):1972–5.
-
Chu DI, Ehlayel AM, Ginsberg JP, Meyers KE, Benton M, Thomas M, et al. Kidney outcomes and hypertension in survivors of Wilms tumor: A prospective cohort study. J Pediatr [Internet]. 2021;230:215. Available from: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&AN=33290810&site=ehost-live
-
Green DM, Wang M, Krasin MJ, Davidoff AM, Srivastava D, Jay DW, et al. Long-term renal function after treatment for unilateral, nonsyndromic Wilms tumor. A report from the St. Jude lifetime cohort study. Pediatr Blood Cancer. 2020 Oct;67(10):e28271.
-
Kostel Bal AS, Yalcin B, Susam-Şen H, Aydin B, Varan A, Kutluk T, et al. Renal late effects after the treatment of unilateral nonsyndromic Wilms tumor. J Pediatr Hematol Oncol [Internet]. 2016;38(4):e147–50. Available from: https://search.ebscohost.com/login.aspx?direct=true&db=mdc&AN=26989912&site=ehost-live
-
Mavinkurve-Groothuis AMC, van de Kracht F, Westland R, van Wijk JAE, Loonen JJ, Schreuder MF. Long-term follow-up of blood pressure and glomerular filtration rate in patients with a solitary functioning kidney: a comparison between Wilms tumor survivors and nephrectomy for other reasons. Pediatr Nephrol Berl Ger [Internet]. 2016;31(3):435–41. Available from: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&AN=26482253&site=ehost-live
-
Stefanowicz J, Kosiak M, Romanowicz G, Owczuk R, Adamkiewicz-Drożyńska E, Balcerska A. Glomerular filtration rate and prevalence of chronic kidney disease in Wilms’ tumour survivors. Pediatr Nephrol Berl Ger. 2011 May;26(5):759–66.
-
Geenen MM, Bakker PJM, Kremer LCM, Kastelein JJP, van Leeuwen FE. Increased prevalence of risk factors for cardiovascular disease in long-term survivors of acute lymphoblastic leukemia and Wilms tumor treated with radiotherapy. Pediatr Blood Cancer [Internet]. 2010;55(4):690–7. Available from: https://search.ebscohost.com/login.aspx?direct=true&db=mdc&AN=20589650&site=ehost-live
-
Termuhlen AM, Tersak JM, Liu Q, Yasui Y, Stovall M, Weathers R, et al. Twenty-five year follow-up of childhood Wilms tumor: a report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer. 2011 Dec 15;57(7):1210–6.
-
Eckschlager T, Radvanska J, Slaby K, Prusa R, Hochova I, Radvansky J. Changes of blood count, lymphocyte subpopulations and immunoglobulin levels in nephroblastoma long term survivors. Neoplasma [Internet]. 2009;56(1):9–12. Available from: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&AN=19152239&site=ehost-live
-
Dudley IM, Sunguc C, Heymer EJ, Winter DL, Teepen JC, Belle FN, et al. Risk of subsequent primary lymphoma in a cohort of 69,460 five-year survivors of childhood and adolescent cancer in Europe: The PanCareSurFup study. Cancer [Internet]. 2023;129(3):426–40. Available from: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&AN=36444554&site=ehost-live
-
Lange JM, Takashima JR, Peterson SM, Kalapurakal JA, Green DM, Breslow NE. Breast cancer in female survivors of Wilms tumor: a report from the national Wilms tumor late effects study. Cancer [Internet]. 2014 Dec;120(23):3722–30. Available from: http://europepmc.org/abstract/MED/25348097
-
Taylor AJ, Winter DL, Pritchard-Jones K, Stiller CA, Frobisher C, Lancashire ER, et al. Second primary neoplasms in survivors of Wilms’ tumour--a population-based cohort study from the British Childhood Cancer Survivor Study. Int J Cancer. 2008 May 1;122(9):2085–93.
-
Children’s Oncology Group. AREN0532: Treatment for Very Low and Standard Risk Favorable Histology Wilms Tumor (A Groupwide Phase III Study). 2011.
-
International Society for Pediatric Oncology - Renal Tumor Study Group. UMBRELLA Protocol SIOP-RTSG 2016 Version 1.2. 2016.
-
International Society for Pediatric Oncology. SIOP Wilms Tumor Protocol 2001. 2001.
-
Laprie A, Bernier V, Padovani L, Martin V, Chargari C, Supiot S, et al. Guide for paediatric radiotherapy procedures. Cancer Radiother [Internet]. 2022;26(1–2):356–67. Available from: http://europepmc.org/abstract/MED/34969622
-
National Cancer Comprehensive Network. NCCN Guidelines Wilms Tumor (Nephroblastoma). 2023.
-
Kalapurakal JA, Lee B, Bautista J, Rigsby C, Helenowski I, Gopalakrishnan M. Cardiac-sparing whole lung intensity modulated radiation therapy in children with Wilms tumor: Final report on technique and abdominal field matching to maximize normal tissue protection. Pr Radiat Oncol [Internet]. 2019 Jan;9(1):e62–73. Available from: http://europepmc.org/abstract/MED/30096378
-
Mul J, Seravalli E, Bosman ME, van de Ven CP, Littooij AS, van Grotel M, et al. Estimated clinical benefit of combining highly conformal target volumes with Volumetric-Modulated Arc Therapy (VMAT) versus conventional flank irradiation in pediatric renal tumors. Clin Transl Radiat Oncol [Internet]. 2021 Jul;29:20–6. Available from: http://europepmc.org/abstract/MED/34027140
-
Mazonakis M, Lyraraki E, Tolia M, Damilakis J. 3D-CRT, IMRT and VMAT for flank irradiation due to pediatric Wilms tumor: A comparative planning study with XCAT phantoms. Phys Med [Internet]. 2022 Nov;103:89–97. Available from: http://europepmc.org/abstract/MED/36257232
-
Guerreiro F, Seravalli E, Janssens G, van den Heuvel-Eibrink M, Lagendijk J, Raaymakers B. Potential benefit of MRI-guided IMRT for flank irradiation in pediatric patients with Wilms’ tumor. Acta Oncol [Internet]. 2019 Feb;58(2):243–50. Available from: http://europepmc.org/abstract/MED/30523729
-
Guerreiro F, Seravalli E, Janssens GO, van de Ven CP, van den Heuvel-Eibrink MM, Raaymakers BW. Intra- and inter-fraction uncertainties during IGRT for Wilms’ tumor. Acta Oncol [Internet]. 2018 Jul;57(7):941–9. Available from: http://europepmc.org/abstract/MED/29457751
-
Kalapurakal JA, Pokhrel D, Gopalakrishnan M, Zhang Y. Advantages of whole-liver intensity modulated radiation therapy in children with Wilms tumor and liver metastasis. Int J Radiat Oncol Biol Phys [Internet]. 2013 Mar;85(3):754–60. Available from: http://europepmc.org/abstract/MED/22763026
-
Stokes CL, Stokes WA, Kalapurakal JA, Paulino AC, Cost NG, Cost CR, et al. Timing of radiation therapy in pediatric Wilms tumor: A report from the National Cancer Database. Int J Radiat Oncol Biol Phys [Internet]. 2018;101(2):453–61. Available from: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&AN=29559286&site=ehost-live
-
International Society for Pediatric Oncology, International Society for Pediatric Oncology - Renal Tumor Study Group - Pediatric Oncology in Developing Countries. Eds. Israels T, Paintsil V, Chitsike I, Renner L, et al. Treatment Guidelines Collaborative Wilms Tumor Africa Project - Phase II Version 1.7. 2020.
-
Prasad M, Vora T, Agarwala S, Laskar S, Arora B, Bansal D, et al. Management of Wilms tumor: ICMR Consensus Document. Indian J Pediatr [Internet]. 2017 Jun;84(6):437–45. Available from: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&AN=28367612&site=ehost-live
-
Verschuur A, Van Tinteren H, Graf N, Bergeron C, Sandstedt B, de Kraker J. Treatment of pulmonary metastases in children with stage IV nephroblastoma with risk-based use of pulmonary radiotherapy. J Clin Oncol Off J Am Soc Clin Oncol [Internet]. 2012;30(28):3533–9. Available from: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&AN=22927531&site=ehost-live
-
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. J Clin Epidemiol [Internet]. 2021 Jun [cited 2022 Jul 28];134:178–89. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0895435621000731
-
Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ [Internet]. 2016 Oct 12 [cited 2023 Feb 17];i4919. Available from: https://www.bmj.com/lookup/doi/10.1136/bmj.i4919
-
Dans AL, Dans L, Silvestre. Painless Evidence-Based Medicine. John Wiley & Sons Ltd.; 2008.
-
Mustafa RA, Santesso N, Brozek J, Akl EA, Walter SD, Norman G, et al. The GRADE approach is reproducible in assessing the quality of evidence of quantitative evidence syntheses. J Clin Epidemiol [Internet]. 2013 Jul [cited 2024 May 18];66(7):736-42.e5. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0895435613000577
-
Alonso-Coello P, Schünemann HJ, Moberg J, Brignardello-Petersen R, Akl EA, Davoli M, et al. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction. BMJ [Internet]. 2016 Jun 28 [cited 2024 Jul 18];i2016. Available from: https://www.bmj.com/lookup/doi/10.1136/bmj.i2016
-
Alonso-Coello P, Oxman AD, Moberg J, Brignardello-Petersen R, Akl EA, Davoli M, et al. GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines. BMJ [Internet]. 2016 Jun 30 [cited 2024 Jul 18];i2089. Available from: https://www.bmj.com/lookup/doi/10.1136/bmj.i2089
-
For the GRADE Working Group, Moberg J, Oxman AD, Rosenbaum S, Schünemann HJ, Guyatt G, Flottorp S, et al. The GRADE Evidence to Decision (EtD) framework for health system and public health decisions. Health Res Policy Syst [Internet]. 2018 Dec [cited 2024 Jul 18];16(1):45. Available from: https://health-policy-systems.biomedcentral.com/articles/10.1186/s12961-018-0320-2
-
Morgan TM, Danish H, Nanda RH, Esiashvili N, Meacham LR. Whole lung irradiation in stage IV Wilms tumor patients: Thyroid dosimetry and outcomes. Pediatr Blood Cancer [Internet]. 2018;65(2). Available from: https://doi.org/10.1002/pbc.26843
-
Demoor-Goldschmidt C, Chiavassa S, Josset S, Mahé MA, Supiot S. Respiratory-gated bilateral pulmonary radiotherapy for Ewing’s sarcoma and nephroblastoma in children and young adults: Dosimetric and clinical feasibility studies. Cancer Radiother J Soc Francaise Radiother Oncol. 2017 Apr;21(2):124–9.
-
Chen MJ, Leao CR, Simoes RCP, Belletti FS, Figueiredo MLS, Cypriano MS. Kidney-sparing whole abdominal irradiation in Wilms tumor: Potential advantages of VMAT technique. Pediatr Blood Cancer. 2020 May;67(5):e28223.
-
Kalapurakal JA, Li SM, Breslow NE, Beckwith JB, Macklis R, Thomas PRM, et al. Influence of radiation therapy delay on abdominal tumor recurrence in patients with favorable histology Wilms’ tumor treated on NWTS-3 and NWTS-4: a report from the National Wilms’ Tumor Study Group. Int J Radiat Oncol [Internet]. 2003 Oct [cited 2023 Feb 17];57(2):495–9. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0360301603005984
-
Dome JS, Cotton CA, Perlman EJ, Breslow NE, Kalapurakal JA, Ritchey ML, et al. Treatment of anaplastic histology Wilms’ tumor: results from the fifth National Wilms’ Tumor Study. J Clin Oncol Off J Am Soc Clin Oncol. 2006 May 20;24(15):2352–8.
-
Kalapurakal JA, Green DM, Haase G, Anderson JR, Dome JS, Grundy PE. Outcomes of children with favorable histology Wilms tumor and peritoneal implants treated in National Wilms Tumor Studies-4 and -5. Int J Radiat Oncol Biol Phys. 2010 Jun 1;77(2):554–8.
-
Breslow NE, Beckwith JB, Haase GM, Kalapurakal JA, Ritchey ML, Shamberger RC, et al. Radiation therapy for favorable histology Wilms tumor: prevention of flank recurrence did not improve survival on National Wilms Tumor Studies 3 and 4. Int J Radiat Oncol Biol Phys. 2006 May 1;65(1):203–9.
-
Vujanić GM, Mifsud W, Chowdhury T, Al-Saadi R, Pritchard-Jones K. Characteristics and outcomes of preoperatively treated patients with anaplastic Wilms tumors registered in the UK SIOP-WT-2001 and IMPORT study cohorts (2002-2020). Cancer [Internet]. 2022;128(8):1666–75. Available from: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&AN=35119702&site=ehost-live
-
Children’s Hospital of Philadelphia. ClinicalTrials.gov. Pencil beam scanning in patients with renal tumors. 2022 [cited 2023 Feb 15]. Available from: https://clinicaltrials.gov/ct2/show/record/NCT03810651
-
St. Jude Children’s Research Hospital. ClinicalTrials.gov. Treatment of newly diagnosed patient’s with Wilms tumor requiring abdominal radiation delivered with proton beam irradiation. 2022 [cited 2023 Feb 15]. Available from: https://clinicaltrials.gov/ct2/show/record/NCT04968990
-
Marcus KJ. ClinicalTrials.Gov. Stereotactic body radiotherapy (SBRT) for pulmonary metastases in ewing sarcoma, rhabdomyosarcoma, and Wilms tumors. 2021 [cited 2023 Feb 15]. Available from: https://clinicaltrials.gov/ct2/show/NCT02581384
-
McAleer MF, Melchior P, Parkes J, Pater L, Rübe C, Saunders D, et al. Harmonica consensus, controversies, and future directions in radiotherapy for pediatric Wilms tumors. Pediatr Blood Cancer [Internet]. 2022 Dec;e30090. Available from: http://europepmc.org/abstract/MED/36482883
-
Seravalli E, Kroon PS, Buatti JM, Hall MD, Mandeville HC, Marcus KJ, et al. The potential role of MR-guided adaptive radiotherapy in pediatric oncology: Results from a SIOPE-COG survey. Clin Transl Radiat Oncol [Internet]. 2021 Jul [cited 2023 Feb 15];29:71–8. Available from: https://linkinghub.elsevier.com/retrieve/pii/S2405630821000525
-
Farooqi A, Siddiqi A, Khan MK, Esiashvili N. Evaluation of radiation dose to cardiac and pulmonary tissue among patients with stage IV Wilms tumor and pulmonary metastases. Pediatr Blood Cancer. 2014 Aug;61(8):1394–7.
-
Rickard KA, Godshall BJ, Loghmani E, Coates TD, Grosfeld JL, Weetman RM, et al. Integration of nutrition support into oncologic treatment protocols for high and low nutritional risk children with Wilms’ tumor. A prospective randomized study. Cancer [Internet]. 1989 Jul 15 [cited 2024 May 19];64(2):491–509. Available from: https://onlinelibrary.wiley.com/doi/10.1002/1097-0142(19890715)64:2<491::AID-CNCR2820640224>3.0.CO;2-Y
-
Mitchell C, Pritchard-Jones K, Shannon R, Hutton C, Stevens S, Machin D, et al. Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms’ tumour: results of a randomised trial (UKW3) by the UK Children’s Cancer Study Group. Eur J Cancer Oxf Engl 1990. 2006 Oct;42(15):2554–62.
-
Powis M, Messahel B, Hobson R, Gornall P, Walker J, Pritchard-Jones K. Surgical complications after immediate nephrectomy versus preoperative chemotherapy in non-metastatic Wilms’ tumour: findings from the 1991-2001 United Kingdom Children’s Cancer Study Group UKW3 Trial. J Pediatr Surg [Internet]. 2013 Nov;48(11):2181–6. Available from: http://europepmc.org/abstract/MED/24210183
-
Pritchard-Jones K, Moroz V, Vujanić G, Powis M, Walker J, Messahel B, et al. Treatment and outcome of Wilms’ tumour patients: an analysis of all cases registered in the UKW3 trial. Ann Oncol [Internet]. 2012 Sep [cited 2023 Mar 18];23(9):2457–63. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0923753419352123
-
Tangco A, Goleta-Dy A, Maramag-Abesamis M. The treatment of Wilms tumor in PGH: a five year experience 1982-1986. Postgrad Pediatr. 1987 Jan;8(1):58–66.
Articles related to the one you are viewing
There are currently no results to show, please try again later
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, which permits use, share — copy and redistribute the material in any medium or format, adapt — remix, transform, and build upon the material, as long as you give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. You may not use the material for commercial purposes. If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original. You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-sa/4.0/.